Skip to main content
Premium Trial:

Request an Annual Quote

S2 Genomics Signs Multiple Distribution Agreements for Asia-Pacific

NEW YORK – S2 Genomics said on Wednesday that it has signed distribution agreements with Scrum, PharmiGene, LnCBio, Thunderbio Science, and TrendBio to promote, sell, and support S2's Singulator 100 system as well as associated products for single-cell genomics and cell biology applications in the Asia-Pacific region.

The firm's agreements will cover Japan (Scrum), South Korea, (LnCBio and Thunderbio Science), Taiwan (PharmiGene), as well as Australia and New Zealand (TrendBio).

S2 Genomics' Singulator system automates the processing of solid tissue samples or nuclei with high yields and from small samples for a wide range of single-cell biology and genomic analyses. The system also allows users to develop their own dissociation protocols, apply their own reagents, and dissociate tissue at low temperature to minimize changes to the transcriptome.

"The Asia-Pacific region is experiencing significant growth in single-cell genomic and cell biology analyses, and that is driving a need for improved sample preparation solutions," Stevan Jovanovich, CEO of S2 Genomics, said in a statement. "Each of these distributors has significant expertise in life sciences, and especially in genomics."

Financial details of the agreements were not disclosed.

S2 Genomics partnered with Riken in February to develop single-cell sequencing applications on the Singulator tissue prep system.